Pfizer Strikes Deal With Impax Over Generic Detrol LA

Law360, New York (August 24, 2012, 7:06 PM EDT) -- Drug makers Pfizer Inc. and Impax Laboratories Inc have settled patent litigation over Impax's bid to produce a generic version of Pfizer's overactive-bladder drug Detrol LA, according to court papers filed Wednesday in New Jersey federal court.

The deal puts an end to the suit Pfizer filed in 2008 after Impax sought approvals from the U.S. Food and Drug Administration to market a generic Detrol LA.The settlement and license agreement between the companies include a permanent injunction blocking Impax from making knockoff versions of extended-release loiterodine,...
To view the full article, register now.